🚨BREAKING STUDY — Ivermectin-Based Treatment Protocols Linked to 100% Survival in Hypoxemic COVID-19 Patients
Here's what the two-part peer-reviewed study found 👇
1️⃣ Rapid Recovery:
Case series from the U.S. (Hazan), Zimbabwe (Stone), and Nigeria (Babalola) showed SpO₂ improved within 24–48 hrs after starting treatment. Protocols included ivermectin, doxycycline, nanosilver, zinc, vitamin C, and vitamin D.
2️⃣ Zero Mortality:
No deaths reported among 119 treated patients—including 61 with baseline SpO₂ ≤ 90%, a severity level that typically requires hospitalization.
3️⃣ Reduced Hospitalization & Deaths:
Using self-controlled methods and external comparisons, significant reductions in hospitalizations and deaths were observed, especially in the Hazan and Stone protocols.
4️⃣ Mechanistic Support:
The multidrug approach targets all phases of COVID-19:
• Antiviral (ivermectin, doxycycline, nanosilver)
• Immune modulation (vitamin D, ivermectin)
• Anticoagulation (aspirin, enoxaparin)
5️⃣ Causality Established:
The findings meet 7 Bradford Hill criteria: temporality, strength of association, biological gradient, biological plausibility, coherence, consistency, and analogy.
6️⃣ Ethical & Urgent Use:
In line with Article 37 of the 2013 Helsinki Declaration, the results justify off-label, compassionate use of repurposed drugs during public health emergencies.
https://lnkd.in/ddDuSFaj | 37 comments on LinkedIn
|
Scooped by
Gilbert C FAURE
onto Hésitations Vaccinales: Observatoire HESIVAXs April 8, 1:25 PM
|